Novel Conjugate Vaccine Technology Enhances Influenza Immune Response
Researchers have successfully demonstrated that a new conjugate vaccine platform significantly boosts human immune responses to influenza, marking a potential shift in how seasonal respiratory illnesses are managed. The study, published this week in the European Medical Journal, indicates that by linking influenza antigens to carrier proteins, the vaccine induces a more robust and durable…